TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006
TCL Archive Senate Passes NIH Reauthorization 87-10; $2.5 Bil. Auhtority For NCI, New Line Items April 10, 1992
TCL Archive Senate Subcommittee Agrees On $1.188 Billion NCI Budgt for FY 1985, $110 Million Increase Over ‘84 June 29, 1984
TCL Archive NCI Tightens Monitoring, Upgrades Staff Training In Attempts To Improve Management Of Contracts January 9, 1981
